2022 Minnesota Medical Licensure Program

 
Enter your answers for ALL educational activities you intend to earn credit for. Then tap Check Answers at the bottom of the page. If you have already completed a course for this program and wish to complete additional courses at this time, please scan and send your information/answers via email to support@cme.edu or fax to 1-800-647-1356.

Show Test Questions

Hide Test Questions

Self-Assessment Answers for Section 1: Best Practices for Treating Pain with Opioid Analgesics
1 . What is one way to reduce the stigma for patients living with chronic pain?
A.
B.
C.
D.
0
2 . Gabapentin has mild-to-moderate benefit in the treatment of:
A.
B.
C.
D.
0
3 . Spinal manipulation has demonstrated improvements in pain and function when used:
A.
B.
C.
D.
0
4 . Which is a true statement about factors to record in the patient record?
A.
B.
C.
D.
0
5 . Which of the following tools assess pain, pain interference, functional components, and quality of life, and was created to assess management of chronic pain in primary care settings?
A.
B.
C.
D.
0
6 . Which is a true statement about screening patients for potential opioid misuse?
A.
B.
C.
D.
0
7 . Patients who are already being prescribed opioids for chronic pain who exhibit an active OUD should be:
A.
B.
C.
D.
0
8 . Which of the following is an example of an opioid-related risk factor appropriately influencing a treatment choice?
A.
B.
C.
D.
0
9 . One sign of an active OUD is:
A.
B.
C.
D.
0
10 . Which of the following statements is true regarding a diagnosis of OUD using DSM-5 criteria?
A.
B.
C.
D.
0
Self-Assessment Answers for Section 2: Evidence-Based Guidance on Prescribing Controlled Substances
11 . Under the Controlled Substances Act, the federal government considers cannabis:
A.
B.
C.
D.
0
12 . The Drug Enforcement Administration has named recurring patterns that might indicate inappropriate controlled substances (CS) prescribing, including which of the following?
A.
B.
C.
D.
0
13 . Attention deficit hyperactivity disorder is characterized by:
A.
B.
C.
D.
0
14 . Optimal treatment for narcolepsy:
A.
B.
C.
D.
0
15 . A common instruction to the patient contained in a treatment agreement for provision of opioids (or another CS) is:
A.
B.
C.
D.
0
16 . Patients with OUD or other problems managing opioids who are tapered or suddenly discontinued from opioids non-collaboratively are at risk for:
A.
B.
C.
D.
0
17 . Which medication should be withdrawn slowly over months when taper is indicated to prevent the possibility of hallucinations?
A.
B.
C.
D.
0
18 . The following FDA-approved medications to treat OUD are:
A.
B.
C.
D.
0
19 . Of the following choices, which drug has been identified by the Drug Enforcement Administration and the National Institute on Drug Abuse as having the highest potential for diversion?
A.
B.
C.
D.
0
20 . Which of the following is a measure to be enacted at a healthcare facility when diversion of CS by a healthcare worker is discovered?
A.
B.
C.
D.
0